Showing 2 posts of 2 posts found.
MSD, known as Merck in the US and Canada, has announced that it has finally decided to discontinue the development …
Care Quality Commission appoints Emily Miles as Chief Executive
National survey aims to improve glaucoma care across the UK
Phase 3 trials support expanded use of Dysport for migraine prevention
Roche secures CE Mark for automated latent tuberculosis blood test
ReproNovo Phase 2 fertility study doses first participant